​

Elicio Therapeutics (ELTX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Elicio Therapeutics Revenue Highlights

00

Elicio Therapeutics Revenue by Period

Elicio Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$28.31M883.06%
2020-12-31$2.88M93.68%
2019-12-31$1.49M-63.09%
2018-12-31$4.03M-38.78%
2013-12-31$6.58M-9.82%
2012-12-31$7.30M-

Elicio Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Elicio Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$1.17M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30--100.00%
2022-03-31$1.65M-93.65%
2021-12-31$25.94M1676.78%
2021-09-30$1.46M170.37%
2021-06-30$540.00K100.00%
2021-03-31--100.00%
2020-12-31$459.00K-44.50%
2020-09-30$827.00K13.44%
2020-06-30$729.00K100.00%
2020-03-31--100.00%
2019-12-31$696.00K-

Elicio Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Elicio Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MOLNMolecular Partners$7.04M$2.74M
APLTApplied Therapeutics$455.00K$1.00M
ACTUActuate Therapeutics--
ELTXElicio Therapeutics--
CRBPCorbus Pharmaceuticals--
NKTXNkarta--
SAVACassava Sciences-$840.00K
RANIRani Therapeutics--
CRDFCardiff Oncology-$121.00K
PEPGPepGen--
MISTMilestone Pharmaceuticals--

ELTX Revenue FAQ

What is Elicio Therapeutics’s yearly revenue?

Elicio Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ELTX's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Elicio Therapeutics’s quarterly revenue?

Elicio Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). ELTX's quarterly revenue for Q4 2024 was $1.17M, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Elicio Therapeutics’s revenue growth rate?

Elicio Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.